| Chr.1 |
Chr.4 (17, 68%) |
Chr.4 (8, 38.1%) & Chr.5 (6, 28.6%) |
Chr.2 (11, 84.6%) |
| Chr.2 |
Chr.2 (20, 95.2%) |
Chr.7 (10, 52.6%) & Chr.2 (6, 31.6%) |
Chr.7 (7, 50%) & Chr.9 (4, 28.6%) |
| Chr.3 |
Chr.9 (15, 60%) & Chr.8 (5, 20%) |
Chr.6 (10, 50%) & Chr.1 (3, 15%) |
Chr. 5 (7, 41.2%) & Chr.12 (3, 17.6%) |
| Chr.4 |
Chr.10 (16, 88.9%) |
Chr.6 (7, 46.6%) & Chr.9 (5, 33.3%) |
Chr.6 (7, 87.5%) |
| Chr.5 |
Chr.3 (27, 93.1%) |
Chr.3 (14, 53.8%) & Chr.8 (9, 34.6%) |
Chr.1 (13, 81.3%) |
| Chr.6 |
Chr.7 (12, 75%) |
Chr.1 (5, 45.4%) & Chr.4 (4, 36.4%) |
Chr.8 (6, 66.7%) |
| Chr.7 |
Chr. 6 (15, 57.7%) |
Chr.2 (10, 40%) & Chr.10 (9, 36%) |
Chr.4 (11, 68.7%) |
| Chr.8 |
Chr.5 (4, 40%) & Chr.8 (3, 30%) |
Chr.2 (4, 44.4%) & Chr.4 (2, 22.2%) |
Chr.1 (4, 44.4%) & Chr.11 (4, 44.4%) |
| Chr.9 |
Chr.1 (51, 96.2%) |
Chr.1 (29, 53.7%), Chr.9 (10, 18.5%) & Chr5 (9, 16.7%) |
Chr.3 (22, 64.7%) & Chr.10 (6, 17.65%) |